Medicine Description gramocef 1000mg
Gramocef 1 gram 8 tablets is a medication that contains cephalexin, a first-generation cephalosporin antibiotic. Its mechanism of action involves the inhibition of bacterial cell wall synthesis. Cephalexin binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, disrupting the synthesis of peptidoglycan, a vital component required for maintaining cell wall integrity. This disruption leads to bacterial lysis and death, making cephalexin effective against a wide range of susceptible bacteria, particularly gram-positive organisms. By interfering with cell wall formation, Gramocef effectively combats infections caused by these bacteria, leading to a reduction in both the infection's severity and clinical symptoms.
Indications and Uses of Gramocef 1 gram 8 tablets
- Treatment of uncomplicated skin and skin structure infections caused by susceptible strains of staphylococci and streptococci.
- Management of respiratory tract infections, including pneumonia and bronchitis, due to susceptible organisms.
- Treatment of urinary tract infections caused by specific bacteria.
- Treatment of bone infections (osteomyelitis) when caused by susceptible organisms.
- Management of infections such as tonsillitis and pharyngitis caused by Group A beta-hemolytic streptococci.
Side Effects of Gramocef 1 gram 8 tablets
- Nausea and vomiting.
- Diarrhea.
- Abdominal pain.
- Rash or allergic reactions.
- Headache.
- Dizziness.
Storage and Handling
Store Gramocef tablets in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use the medication past its expiration date.
Patient Advice and Precautions
Always complete the full course of Gramocef as prescribed by your healthcare provider, even if symptoms improve before finishing the medication. Inform your doctor about any allergies or previous adverse reactions to cephalosporins or penicillins. Be cautious of potential interactions with other medications and consult your healthcare provider before starting any new drugs during the treatment period.